FBInvestor
Stocks / Revive Therapeutics Ltd
Institutional Ownership

Revive Therapeutics Ltd

CUSIP 761516103COMRVVTFQ1 2026

Earnings

Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).

Coming soon